OBJECTIVE: To study the risk factors for infection with extended-spectrum beta-lactamase (ESBL) producing strains in children. METHODS: The clinical data of 242 pediatric in-patients with lower respiratory tract infections from February 2009 to January 2011 were retrospectively analyzed. The risk factors of ESBL-producing strain infections were investigated using univariate analysis and multivariate logistic regression analysis. RESULTS: Univariate analysis showed that six factors were related with ESBL-producing strain infections: repeated sucking of phlegm (OR: 2.279, P<0.01), tracheal intubation(OR: 3.101, P<0.01), administration of the third generation cephalosporin for more than three days (OR: 3.628, P<0.01), admission to the pediatric intensive care unit (PICU) (OR: 2.378, P<0.01), indwelling of nasogastric tube (OR: 2.460, P<0.01), prophylactic use of antibiotics (OR: 1.747, P<0.05). Multivariate logistic regression showed that the application of the third-generation cephalosporin for more than three days (OR: 5.672, P<0.01), repeated sucking of phlegm (OR: 3.917, P<0.01), tracheal intubation (OR: 3.717, P<0.01), indwelling of nasogastric tube (OR: 2.961, P<0.01）, and admission to PICU (OR: 3.237, P<0.01）were the independent risk factors for the infections. CONCLUSIONS: The infections of ESBL-producing strains are caused by many factors, among which the application of the thirdgeneration cephalosporin for more than three days, invasive operations, and admission to PICU are the independent risk factors.
Key words
Extended-spectrum beta-lactamase /
Risk factor /
Child
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
References
［1］Knothe H, Shah P, Krenery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime,cefoxitin,cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens［J］. Infection, 1983, 11(6):315-317.
［2］Grover SS, Sharma M, Chattopadhya D, Kapoor H, Pasha ST, Singh G.Phenotypic and genotypic detection of ESBL mediated cephalosporin resistance in Klebsiella pneumoniae:emergence of high resistance against cefepime, the fourth generation cephalosporin［J］. J Infect, 2006, 53(4): 279-288.
［3］Naumovski L, Quinn JP, Miyashiro D, Patel M, Bush K, Singer SB, et al. Outbreak of ceftazidime resistance due to a novel extended-spectrum beta-lactamase in isolates from cancer patients［J］. Antimicrob Agents Chemother, 1992, 36(9):1991-1996.
［4］陶勇，姚杰，贾建安, 吕晴. 856株下呼吸道感染肠杆菌科细菌的ESBLs检测及相关分析［J］.临床肺科杂志，2009，14（5）：614-615.
［5］韩晓华，杜悦，刘勇，刘春峰，尚云晓，袁壮. 小儿院内获得性肺炎产超广谱β-内酰胺酶细菌的耐药性及危险因素分析［J］.中国当代儿科杂志，2005,7（1）：34-38.
［6］Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic-resistant Klebsiella and Escherichia coli in nursing homes［J］. JAMA, 1999, 281(6): 517-523.
［7］金嵘，李向阳，孔海深，李国雄，王伟.超广谱β-内酰胺酶细菌致医院内感染危险因素的病例对照研究［J］.中华预防医学杂志，2003,37（1）：41-44.
［8］李永祥，宋秀兰，丁曙光，张黎霞.大肠埃希菌与肺炎克雷伯菌产ESBLs及耐药性变迁［J］.中华医院感染学杂志，2007,17（6）：734-736.
［9］Chang FY, Siu LK, Fung CP, Huang MH, Ho M. Diversity of SHV and TEM β-lactamases in Klebsiella pneumoniae:gene evolution in northern Taiwan and two novel β-lactamases, SHV-25 and SHV-26［J］.Antimicrob Agents Chemother, 2001, 45(9): 2407-2413.
［10］杨善浦，董虹.小儿下呼吸道感染病原菌产超广谱β-内酰胺酶的检测分析［J］.中华医院感染学杂志，2010,20（23）：3806-3808.
PDF(967 KB)
